Scientists Design Molecule to Slow SARS-Cov-2 Infection
A team of scientists have designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be ...
A team of scientists have designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be ...
Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats ENA Respiratory has been awarded ...
Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent ...
As the coronavirus waves keep coming and cases are on the rise once again, the National Institutes of Health (NIH) ...
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against ...
New research shows for the first time why the antiviral drug remdesivir works against some viruses but not others—a finding ...
COVID-19 is both contracted and transmitted by inhalation of droplets or aerosols containing the SARS-CoV-2 virus, and the nose is ...
The Johns Hopkins Malaria Research Institute will host the 7th Future of Malaria Research Symposium on November 12, prior to the American Society ...
Scientists at Washington University School of Medicine in St. Louis are collaborating with the NIH researchers to test the MM3122 ...
Named one of the top ten threats in 2019 by the World Health Organization, dengue is critically important to global health ...
USAMRIID will test Navrogen's NAV-201 small molecule against SARS-COV-2 infected human epithelial cells in vitro and in in vivo rodent studies Navrogen, Inc. has ...
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking applications to establish the Antiviral Drug Discovery (AViDD) program ...
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that ...
While the world awaits broad distribution of COVID-19 vaccines, researchers at Ohio University just published highly significant and timely results ...
Last month, the Food and Drug Administration (FDA) gave its first full approval for a COVID-19 therapeutic to Gilead Sciences' ...
How can we battle these infectious agents such as Ebola virus disease (EVD) that reproduce by hijacking cells and reprogramming ...
The U.S. Food and Drug Administration this week approved Inmazeb, previously called REGN-EB3, a mixture of three monoclonal antibodies made ...
The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a ...
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. ...
Researchers at the University of Alberta have discovered a novel, second mechanism of action by the antiviral drug remdesivir against ...